| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.005 |